Go to:
Logótipo
You are here: Start > Publications > View > Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?
Concurso de Escrita Criativa da FEUP
Publication

Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?

Title
Mapping Chromone-3-Phenylcarboxamide Pharmacophore: Quid Est Veritas?
Type
Article in International Scientific Journal
Year
2021
Authors
Mesiti, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gaspar, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Chavarria, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Maruca, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rocca, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Martins, EG
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Barreiro, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernandes, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gul, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Keminer, O
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alcaro, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernanda Borges
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 64
ISSN: 0022-2623
Other information
Authenticus ID: P-00V-5MW
Abstract (EN): Chromone-3-phenylcarboxamides (Crom-1 and Crom-2) were identified as potent, selective, and reversible inhibitors of human monoamine oxidase B (hMAO-B). Since they exhibit some absorption, distribution, metabolism, and excretion (ADME)-toxicity liabilities, new derivatives were synthesized to map the chemical structural features that compose the pharmacophore, a process vital for lead optimization. Structure-activity relationship data, supported by molecular docking studies, provided a rationale for the contribution of the heterocycle's rigidity, the carbonyl group, and the benzopyran heteroatom for hMAO-B inhibitory activity. From the study, N-(3-chlorophenyl)-4H-thiochromone-3-carboxamide (31) (hMAO-B IC50 = 1.52 +/- 0.15 nM) emerged as a reversible tight binding inhibitor with an improved pharmacological profile. In in vitro ADME-toxicity studies, compound 31 showed a safe cytotoxicity profile in Caco-2, SH-SY5Y, HUVEC, HEK-293, and MCF-7 cells, did not present cardiotoxic effects, and did not affect P-gp transport activity. Compound 31 also protected SH-SY5Y cells from iron(III)-induced damage. Collectively, these studies highlighted compound 31 as the first-in-class and a suitable candidate for in vivo preclinical investigation.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 14
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis (2018)
Article in International Scientific Journal
Reis, J; Manzella, N; Fernando Cagide; Mialet Perez, J; Uriarte, E; Parini, A; Fernanda Borges; Binda, C
Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase (2002)
Article in International Scientific Journal
learmonth, da; vieira-coelho, ma; benes, j; alves, pc; borges, n; freitas, ap; soares-da-silva, p
Synthesis of Tetrahydronaphthalene Lignan Esters by Intramolecular Cyclization of Ethyl p-Azidophenyl-2-phenylalkanoates and Evaluation of the Growth Inhibition of Human Tumor Cell Lines (2011)
Article in International Scientific Journal
Orlando Pinto; Joao Sardinha; Pedro D Vaz; Fatima Piedade; Maria J Calhorda; Rudolph Abramovitch; Nair Nazareth; Madalena Pinto; Maria S J Nascimento; Amelia P Rauter
Synthesis, biological evaluation, and molecular modeling studies of a novel peripherally selective inhibitor of catechol-O-methyltransferase (2004)
Article in International Scientific Journal
learmonth, da; palma, pn; vieira-coelho, ma; soares-da-silva, p
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors (2011)
Article in International Scientific Journal
Matos, MJ; Terán, C; Pérez Castillo, Y; Uriarte, E; Santana, L; Viña, D

See all (42)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-07-20 at 21:14:54 | Acceptable Use Policy | Data Protection Policy | Complaint Portal